PSMA PET/CT: Joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0 Guidelines


Authors: Fendler, W. P.; Eiber, M.; Beheshti, M.; Bomanji, J.; Calais, J.; Ceci, F.; Cho, S. Y.; Fanti, S.; Giesel, F. L.; Goffin, K.; Haberkorn, U.; Jacene, H.; Koo, P. J.; Kopka, K.; Krause, B. J.; Lindenberg, L.; Marcus, C.; Mottaghy, F. M.; Oprea-Lager, D. E.; Osborne, J. R.; Piert, M.; Rowe, S. P.; Schöder, H.; Wan, S.; Wester, H. J.; Hope, T. A.; Herrmann, K.
Title: PSMA PET/CT: Joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
Abstract: Here we aim to provide updated guidance and standards for the indication, acquisition, and interpretation of PSMA PET/CT for prostate cancer imaging. Procedures and characteristics are reported for a variety of available PSMA small radioligands. Different scenarios for the clinical use of PSMA-ligand PET/CT are discussed. This document provides clinicians and technicians with the best available evidence, to support the implementation of PSMA PET/CT imaging in research and routine practice. © 2023, The Author(s).
Keywords: staging; diagnostic imaging; prostate cancer; prostatic neoplasms; prostate tumor; pet; oligopeptides; guideline; gallium; oligopeptide; restaging; procedures; psma; edetic acid; gallium radioisotopes; humans; human; male; positron emission tomography-computed tomography; positron emission tomography computed tomography
Journal Title: European Journal of Nuclear Medicine and Molecular Imaging
Volume: 50
Issue: 5
ISSN: 1619-7070
Publisher: Springer  
Date Published: 2023-01-01
Start Page: 1466
End Page: 1486
Language: English
DOI: 10.1007/s00259-022-06089-w
PUBMED: 36604326
PROVIDER: scopus
PMCID: PMC10027805
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Heiko Schoder
    542 Schoder